CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model

Overview of attention for article published in Frontiers in oncology, April 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 12,051 followers.

New research: CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model: The interaction of lymphoma cells with their microenvironment has an important role in disease pathogenesis and is being… https://t.co

09 May 2020

Reply Repost Favourite

CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. #lymphoma #lymsm https://t.co/7jFk7qhECk

21 Apr 2020

Reply Repost Favourite

New article: CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. https://t.co/J5kjJ2MJTt #DLBCL #lymsm #hematology

21 Apr 2020

Reply Repost Favourite

"#CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model" Felce SL [..] Banham AH. Front Oncol 2020-04-03. https://t.co/dVBlTWqBR6

08 Apr 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.